YCBD logo

cbdMD (YCBD)

Profile

Full Name

cbdMD, Inc.

Ticker Symbol

YCBD

Exchange

NYSE American

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

November 17, 2017

Indexes

Not included

Website

http://www.cbdmd.com

Employees

42

Key Details

Price

$0.22(-21.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$19.48M(-19.35% YoY)

Annual EPS

-$1.79(+86.56% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.22
YCBD price is $0.22

30-Day Relative Volume

0.92
YCBD 30-day relative volume is 0.92

Price Performance

Price Most recent change

-21.22%
YCBD price was down -21.22% on Apr 11, 2025

Price YTD change

-41.6%
YCBD price is down -41.6% since January 1st

Price 1-year change

-78.53%
YCBD price is down -78.53% year-on-year

Price 3-year change

-99.39%
YCBD price is down -99.39% over the past 3 years

Price Range

Price All-time high

$381.60
YCBD price is currently -99.94% below its historical high of $381.60

Price 3-year low

$0.18
YCBD price is currently +20.99% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.37M
YCBD market capitalization is $1.37 million

Market cap 3-year change

-97.11%
YCBD market capitalization is down -97.11% over the past 3 years

Market cap All-time high

$328.88M
YCBD market capitalization is currently -99.58% below its historical high of $328.88 million

Market cap sector rank

4.85%
YCBD market capitalization is higher than 4.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+105.66%
YCBD shares outstanding is up +105.66% year-on-year

Shares Outstanding 3-Year Change

+374.85%
YCBD shares outstanding is up +374.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
YCBD beta is 0.78

200-day SMA

$0.47
YCBD price is currently -53.56% below its 200-day simple moving average

50-day SMA

$0.37
YCBD price is currently -40.97% below its 50-day simple moving average

RSI

38.33
YCBD 14-day relative strength index is 38.33

Volume

0.92
YCBD 30-day relative volume is 0.92

ATR

$0.05
YCBD average true range is $0.05

10-day Historical Volatility

293.25%
YCBD 10-day historical volatility is 293.25%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$19.48M
YCBD annual revenue is $19.48 million

Revenue Analysts estimate

$21.58M
YCBD annual revenue is currently -9.73% lower than the consensus analysts' forecast

Revenue 1-year change

-19.35%
YCBD annual revenue is down -19.35% year-on-year

Revenue Sector rank

33.93%
YCBD annual revenue is higher than 33.93% of companies in Healthcare sector

EPS

EPS

-$1.79
YCBD annual earnings per share is -$1.79

EPS Analysts estimate

-
YCBD annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+86.56%
YCBD annual earnings per share is up +86.56% year-on-year

EPS Sector rank

40.71%
YCBD annual earnings per share is higher than 40.71% of companies in Healthcare sector

Profit

Gross profit

$12.00M
YCBD annual gross profit is $12.00 million

Gross margin

61.57%
YCBD annual gross profit margin is 61.57%

Operating profit

-$3.32M
YCBD annual operating income is -$3.32 million

Operating margin

-17.02%
YCBD annual operating profit margin is -17.02%

Net income

-$3.70M
YCBD annual net profit is -$3.70 million

Net margin

-18.99%
YCBD annual net profit margin is -18.99%

Expenses

Total expenses

$22.80M
YCBD annual total expenses is $22.80 million

Operating expenses

$15.31M
YCBD annual total operating expenses is $15.31 million

Cost of goods sold

$7.49M
YCBD annual cost of goods sold is $7.49 million

Selling, general & administrative expenses

$12.62M
YCBD annual SGA is $12.62 million

Depreciation and amortization

$1.82M
YCBD annual depreciation & amortization is $1.82 million

Interest expense

-
YCBD annual interest expense value is unknown

Income tax

$0.00
YCBD annual income tax is $0.00

EBIT & EBITDA

EBIT

-$3.32M
YCBD annual earnings before interest & taxes is -$3.32 million

EBITDA

-$1.50M
YCBD annual EBITDA is -$1.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$10.58M
YCBD annual total assets is $10.58 million

Non current assets

$4.19M
YCBD annual long term assets is $4.19 million

Current assets

$6.39M
YCBD annual total current assets is $6.39 million

Cash and cash equivalents

$2.45M
YCBD annual cash & cash equivalents is $2.45 million

Accounts receivable

$983.90K
YCBD annual accounts receivable is $983.90 thousand

Inventory

$2.37M
YCBD annual inventory is $2.37 million

Liabilities

Total liabilities

$8.62M
YCBD annual total liabilities is $8.62 million

Long term liabilities

$0.00
YCBD annual total long term liabilities is $0.00

Current liabilities

$8.62M
YCBD annual total current liabilities is $8.62 million

Accounts payable

$1.54M
YCBD annual accounts payable is $1.54 million

Debt

Total debt

$1.27M
YCBD annual total debt is $1.27 million

Total debt 1-year change

-65.52%
YCBD annual total debt is down -65.52% year-on-year

Long term debt

$0.00
YCBD annual long term debt is $0.00

Short term debt

$1.27M
YCBD annual short term debt is $1.27 million

Equity & Capital

Shareholders equity

$1.96M
YCBD annual stockholders equity is $1.96 million

Book value

$1.96M
YCBD annual book value is $1.96 million

Retained earnings

-$182.07M
YCBD annual retained earnings is -$182.07 million

Working capital

-$2.23M
YCBD annual working capital is -$2.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$352.80K
YCBD annual cash flow from operations is -$352.80 thousand

Cash from operations 1-year change

+91.8%
YCBD annual cash flow from operations is up +91.8% year-on-year

Cash from investing

-$290.00K
YCBD annual cash flow from investing activities is -$290.00 thousand

Cash from investing 1-year change

-141.28%
YCBD annual cash flow from investing activities is down -141.28% year-on-year

Cash from financing

$1.30M
YCBD annual cash flow from financing activities is $1.30 million

Cash from financing 1-year change

+198.09%
YCBD annual cash flow from financing activities is up +198.09% year-on-year

CAPEX

CAPEX

$290.00K
YCBD annual capital expenditures is $290.00 thousand

CAPEX 1-year change

-2.52%
YCBD annual capital expenditures is down -2.52% year-on-year

Free Cash Flow

Free cash flow

-$642.80K
YCBD annual free cash flow is -$642.80 thousand

Free cash flow 1-year change

+86.02%
YCBD annual free cash flow is up +86.02% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.57%
YCBD annual gross profit margin is 61.57%

Operating margin

-17.02%
YCBD annual operating profit margin is -17.02%

Net margin

-18.99%
YCBD annual net profit margin is -18.99%

ROA & ROE

ROA

-27.64%
YCBD annual return on assets is -27.64%

ROE

-67.31%
YCBD annual return on equity is -67.31%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
YCBD price to earnings ratio value is unknown

PE ratio Sector rank

-
YCBD price to earnings ratio is unknown

PB Ratio

PB ratio

0.77
YCBD price to book ratio is 0.77

PB ratio Sector rank

39.47%
YCBD price to book ratio is higher than 39.47% of companies in Healthcare sector

PS Ratio

PS ratio

0.07
YCBD price to sales ratio is 0.07

PS ratio Sector rank

4.49%
YCBD price to sales ratio is higher than 4.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.03M
YCBD enterprise value is $1.03 million

Enterprise value Sector rank

14.78%
YCBD enterprise value is higher than 14.78% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.69
YCBD EV/EBITDA is -1.69

EV/EBITDA Sector rank

34.4%
YCBD EV/EBITDA is higher than 34.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.74
YCBD annual current ratio is 0.74

Quick ratio

0.47
YCBD annual quick ratio is 0.47

Leverage

Debt to equity

0.60
YCBD annual debt to equity ratio is 0.60

Interest coverage ratio

-
YCBD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
YCBD piotroski f-score is 4

Altman Z-Score

-23.44
YCBD altman z-score is -23.44

Analyst ratings

Recent major analysts updates

Oct 5, 23 Maxim Group
Buy

Institutional Ownership

Similar stocks

VINC logo
Vincerx Pharma (VINC)
UPC logo
Universe Pharmaceuticals (UPC)
PCSA logo
Processa Pharmaceuticals (PCSA)
PTPI logo
Petros Pharmaceuticals (PTPI)
BJDX logo
Bluejay Diagnostics (BJDX)
APVO logo
Aptevo Therapeutics (APVO)
APDN logo
Applied DNA Sciences (APDN)
NAYA Biosciences (NAYA)
AVGR logo
Avinger (AVGR)
  • What is the ticker symbol for cbdMD?
  • Does cbdMD pay dividends?
  • What sector is cbdMD in?
  • What industry is cbdMD in?
  • What country is cbdMD based in?
  • When did cbdMD go public?
  • Is cbdMD in the S&P 500?
  • Is cbdMD in the NASDAQ 100?
  • Is cbdMD in the Dow Jones?
  • When was cbdMD's last earnings report?
  • When does cbdMD report earnings?
  • Should I buy cbdMD stock now?

What is the ticker symbol for cbdMD?

The ticker symbol for cbdMD is NYSE American:YCBD

Does cbdMD pay dividends?

No, cbdMD does not pay dividends

What sector is cbdMD in?

cbdMD is in the Healthcare sector

What industry is cbdMD in?

cbdMD is in the Drug Manufacturers - Specialty & Generic industry

What country is cbdMD based in?

cbdMD is headquartered in United States

When did cbdMD go public?

cbdMD's initial public offering (IPO) was on November 17, 2017

Is cbdMD in the S&P 500?

No, cbdMD is not included in the S&P 500 index

Is cbdMD in the NASDAQ 100?

No, cbdMD is not included in the NASDAQ 100 index

Is cbdMD in the Dow Jones?

No, cbdMD is not included in the Dow Jones index

When was cbdMD's last earnings report?

cbdMD's most recent earnings report was on Feb 13, 2025

When does cbdMD report earnings?

The next expected earnings date for cbdMD is May 15, 2025

Should I buy cbdMD stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page